EQS-News: Abivax reports two-year efficacy and safety data of obefazimod phase 2b maintenance trial in ulcerative colitis

EQS-News: ABIVAX / Key word(s): Study results Abivax reports two-year efficacy and safety data of obefazimod phase 2b maintenance tri...

Related Keywords

France ,Paris ,France General ,New York ,United States ,Sheldon Sloan ,Hartmutj Ehrlich ,Jeanene Timberlake ,Pbruce Sands ,Regina Jehle ,Ligia Vela Reid ,Burrillb Crohn ,Ghislaine Gasparetto ,Enregistrement Universel ,Anne Hennecke ,Relations Investors Europe ,Rooney Partners ,Mc Services ,Icahn School Of Medicine At Mount Sinai ,Steering Committee For The Phase ,Euronext ,Euronext Paris ,Icahn School ,Mount Sinai ,Mount Sinai Health System ,Steering Committee ,Mayo Score ,Truffle Capital ,Although Abivax ,French Autorit ,Des March ,Modified Mayo Score ,